Scarica l'app Stockscreener
0.61
18.67%
-0.14
Dopo l'orario di chiusura:
.64
0.03
+4.92%
Precedente Chiudi:
$0.75
Aprire:
$0.686
Volume 24 ore:
2.19M
Relative Volume:
4.76
Capitalizzazione di mercato:
$721.96K
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-87.45%
1M Prestazione:
-93.48%
6M Prestazione:
-98.99%
1 anno Prestazione:
-99.93%
Intervallo 1D:
$0.5817
$0.73
Intervallo di 1 settimana:
$0.5817
$2.04
Portata 52W:
$0.5817
$1,236.24
AEON Biopharma Inc. Stock (AEON) Company Profile
Nome
AEON Biopharma Inc.
Settore
Industria
Telefono
(949) 354-6499
Indirizzo
5 Park Plaza, Suite 1750, Irvine
Confronta AEON con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AEON
AEON Biopharma Inc.
|
0.61 | 721.96K | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.31 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
684.87 | 75.07B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
622.61 | 37.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.53 | 31.79B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
111.56 | 27.34B | 3.30B | -501.07M | 1.03B | -2.1146 |
AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-08-18 | Iniziato | H.C. Wainwright | Buy |
AEON Biopharma Inc. Borsa (AEON) Ultime notizie
Cervical Dystonia Market Expected to Experience Major Growth - openPR
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week - Asianet Newsable
AEON Biopharma, Inc. Deloitte, Inc. Announces Update of Phase 2 Double Blind Study of ABP-450 in the Treatment of Migraine - Marketscreener.com
AEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Interim Analysis of ABP-450 in the Preventive Treatment of Chronic Migraine - Marketscreener.com
AEON Biopharma, Inc. Announces Executive Changes -May 16, 2024 at 04:28 pm EDT - Marketscreener.com
AEON Biopharma, Inc. Announces Strategic Reprioritization to Pursue A Biosimilar Pathway for ABP-450 - Marketscreener.com
AEON Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com
Stock market news: AEON Biopharma plummented by 65.33% while Enveric Biosciences skyrocketed by 90.68% during midday trading - Business Upturn
Stock market today: AEON Biopharma plunged by 63.17% while Enveric Biosciences surged by 124.66% in early trading - Business Upturn
AEON Biopharma To Implement 1-for-72 Reverse Stock Split For Compliance With NYSE Rules - Nasdaq
AEON Biopharma executes reverse stock split to comply with NYSE standards - Investing.com Australia
Aeon Biopharma Approves 1-For-72 Reverse Stock Split -February 24, 2025 at 02:53 pm EST - Marketscreener.com
AEON Biopharma shares plunge as it announces reverse stock split - MSN
AEON Biopharma Stockholders Approve Key Proposals - TipRanks
AEON Biopharma, Inc. Announces Reverse Stock Split - The Manila Times
AEON Biopharma Announces 1-for-72 Reverse Stock Split Effective February 26, 2025 - Nasdaq
Can AEON's 1-for-72 Reverse Split Save Its NYSE Listing Status? - StockTitan
AEON Biopharma Inc (AEON) Shares Down Despite Recent Market Volatility - The News Heater
Watch this stock’s price performance: AEON Biopharma Inc (AMEX:AEON) - US Post News
AEON Biopharma Receives Notice Of Non-Compliance With NYSE American Listing Standards - Nasdaq
AEON Biopharma Inc (AMEX: AEON) Could See A Rise In Prices Shortly. - Marketing Sentinel
Investor’s Delight: AEON Biopharma Inc (AEON) Closes Weak at 0.13, Down -6.93 - The Dwinnex
AEON Biopharma receives NYSE non-compliance notice - MSN
AEON Biopharma, Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - The Manila Times
Aeon Biopharma Gets NYSE American Noncompliance Notice -February 07, 2025 at 05:06 pm EST - Marketscreener.com
Aeon Biopharma Receives Notice Of Non-Compliance With NYSE American Continued Listing Standards - Marketscreener.com
AEON Biopharma Inc [AEON] Stock trading around $0.14 per share: What’s Next? - The DBT News
AEON Biopharma, Inc. Receives Notice of Non-Compliance from NYSE American Due to Stockholders' Deficit - Nasdaq
AEON Biopharma Inc Inc. (AEON) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
Is AEON Biopharma Inc (AMEX: AEON) Still Trending? - Stocks Register
Take off with AEON Biopharma Inc (AEON): Get ready for trading - SETE News
Analyzing AEON’s current quarter earnings projections - US Post News
Retail Traders Flocked To These 5 Biotech Stocks In January — Here’s Why - Asianet Newsable
AEON Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 - Marketscreener.com
Midday Stock Roundup: FivePoint Holdings Jumps 36% - Orange County Business Journal
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Kairos, OS Therapies, AEON See Highest Weekly Spike In Retail Following Among Biotechs: Here's Why - NewsBreak
Irvine-based Aeon Biopharma Raises $20 Million - Orange County Business Journal
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Dow Jumps Over 300 Points; US Industrial Production Beats Estimates - Benzinga
Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - Benzinga
AEON Biopharma Inc (AMEX: AEON) -9.93% Decline Turns Investors Away - Stocks Register
AEON Biopharma (NASDAQ:AEON) Stock Price Down 9.9% – What’s Next? - Defense World
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
AEON Stock Plummets to 52-Week Low at $0.16 Amid Market Turbulence - Investing.com
AEON’s Value Tanks As It Closes $20m Offering Amid Botox Biosimilar Aspirations - News & Insights
AEON Biopharma announces share offering - MSN
AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering - The Manila Times
AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering - Benzinga
AEON Biopharma Raises $20M in Public Offering with Dual-Warrant Structure - StockTitan
Form 424B5 AEON Biopharma, Inc. - StreetInsider.com
AEON Biopharma Inc. Azioni (AEON) Dati Finanziari
Non sono disponibili dati finanziari per AEON Biopharma Inc. (AEON). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
6.45%
1.23%
Capitalizzazione:
|
Volume (24 ore):